FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to hematology, and aims at treating immune thrombocytopenia (ITP). Allelic polymorphism of glycoprotein genes GpIIb T2622G and GpIa A1648G responsible for formation of HPA-3 and -5 systems, respectively. If observing the genotype GpIIb heterozygote, genotype 2622TG is followed by corticosteroid therapy. If observing genotype GpIa homozygotes of genotype 1648AA, splenectomy or therapy with thrombopoietin receptor agonists is performed.
EFFECT: proposed method enables optimizing the management of the ITP based on studying the genetic characteristics of the individual patient and significantly reducing the cost of the therapy.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF IDIOPHATIC THROMBOCYTOPENIC PURPURA OF CHILDREN | 0 |
|
SU1242180A1 |
| METHOD FOR TREATING THERMOCYTOPENIC PURPURA IN CHILDREN | 0 |
|
SU1718951A1 |
| METHOD OF TREATMENT OF AUTOIMMUNE GENERAL DISEASES AND MEDICAL PRODUCT | 2007 |
|
RU2361588C2 |
| METHOD OF SURGICAL TREATMENT OF CHILDREN WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2000 |
|
RU2168947C1 |
| METHOD FOR THE DIAGNOSIS OF ALLOIMMUNE THROMBOCYTOPENIA OF THE NEWBORN | 2015 |
|
RU2611348C1 |
| METHOD FOR PREDICTION OF COURSE OF IMMUNE THROMBOCYTOPENIA FOLLOWING SPLENECTOMY BY WEIGHT OF CD4+ T-LYMPHOCYTES OF SPLEEN | 2015 |
|
RU2599021C1 |
| METHOD OF TREATING HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS | 2024 |
|
RU2829414C1 |
| METHOD OF DETERMINING FACTORS OF PREDICTION OF SEVERE HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN DIAGNOSTICS | 2009 |
|
RU2400750C1 |
| METHOD OF TREATING LOCAL RECURRENCE OF PANCREATIC CANCER FOLLOWING RADICAL SURGERY | 2013 |
|
RU2526802C1 |
| METHOD FOR MORPHOMETRIC EVALUATION OF IMMUNE THROMBOCYTOPENIA COURSE PREDICTION AFTER SPLENECTOMY BASED ON SPLEEN CD4+/CD8+ T-LYMPHOCYTES WEIGHTS RATIO | 2016 |
|
RU2621627C1 |
